BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 18666155)

  • 1. Comparison of T(1) and T(2) metabolite relaxation times in glioma and normal brain at 3T.
    Li Y; Srinivasan R; Ratiney H; Lu Y; Chang SM; Nelson SJ
    J Magn Reson Imaging; 2008 Aug; 28(2):342-50. PubMed ID: 18666155
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Measurements of diagnostic examination performance using quantitative apparent diffusion coefficient and proton MR spectroscopic imaging in the preoperative evaluation of tumor grade in cerebral gliomas.
    Server A; Kulle B; Gadmar ØB; Josefsen R; Kumar T; Nakstad PH
    Eur J Radiol; 2011 Nov; 80(2):462-70. PubMed ID: 20708868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proton magnetic resonance spectroscopy in the distinction of high-grade cerebral gliomas from single metastatic brain tumors.
    Server A; Josefsen R; Kulle B; Maehlen J; Schellhorn T; Gadmar Ø; Kumar T; Haakonsen M; Langberg CW; Nakstad PH
    Acta Radiol; 2010 Apr; 51(3):316-25. PubMed ID: 20092374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glioma grading: sensitivity, specificity, and predictive values of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging.
    Law M; Yang S; Wang H; Babb JS; Johnson G; Cha S; Knopp EA; Zagzag D
    AJNR Am J Neuroradiol; 2003; 24(10):1989-98. PubMed ID: 14625221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 3T 1H-MR spectroscopy in grading of cerebral gliomas: comparison of short and intermediate echo time sequences.
    Kim JH; Chang KH; Na DG; Song IC; Kwon BJ; Han MH; Kim K
    AJNR Am J Neuroradiol; 2006 Aug; 27(7):1412-8. PubMed ID: 16908549
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury.
    Zeng QS; Li CF; Zhang K; Liu H; Kang XS; Zhen JH
    J Neurooncol; 2007 Aug; 84(1):63-9. PubMed ID: 17619225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Association between Whole-Brain MR Spectroscopy and IDH Mutation Status in Gliomas.
    Goryawala M; Saraf-Lavi E; Nagornaya N; Heros D; Komotar R; Maudsley AA
    J Neuroimaging; 2020 Jan; 30(1):58-64. PubMed ID: 31868291
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Computation of brain metabolite ratios in single-voxel proton MR spectroscopy: comparison between semiautomatic and automatic software.
    Mazzoni LN; Belli G; Ginestroni A; Pratesi A; Agnoloni S; Diciotti S; Mascalchi M
    Radiol Med; 2010 Feb; 115(1):125-32. PubMed ID: 19562268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Preoperative grading of gliomas by using metabolite quantification with high-spatial-resolution proton MR spectroscopic imaging.
    Stadlbauer A; Gruber S; Nimsky C; Fahlbusch R; Hammen T; Buslei R; Tomandl B; Moser E; Ganslandt O
    Radiology; 2006 Mar; 238(3):958-69. PubMed ID: 16424238
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fast mapping of the T2 relaxation time of cerebral metabolites using proton echo-planar spectroscopic imaging (PEPSI).
    Tsai SY; Posse S; Lin YR; Ko CW; Otazo R; Chung HW; Lin FH
    Magn Reson Med; 2007 May; 57(5):859-65. PubMed ID: 17457864
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved delineation of brain tumors: an automated method for segmentation based on pathologic changes of 1H-MRSI metabolites in gliomas.
    Stadlbauer A; Moser E; Gruber S; Buslei R; Nimsky C; Fahlbusch R; Ganslandt O
    Neuroimage; 2004 Oct; 23(2):454-61. PubMed ID: 15488395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proton magnetic resonance spectroscopy of normal human brain and glioma: a quantitative in vivo study.
    Tong ZY; Toshiaki Y; Wang YJ
    Chin Med J (Engl); 2005 Aug; 118(15):1251-7. PubMed ID: 16117877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy.
    Weybright P; Sundgren PC; Maly P; Hassan DG; Nan B; Rohrer S; Junck L
    AJR Am J Roentgenol; 2005 Dec; 185(6):1471-6. PubMed ID: 16304000
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Longitudinal multivoxel MR spectroscopy study of pediatric diffuse brainstem gliomas treated with radiotherapy.
    Laprie A; Pirzkall A; Haas-Kogan DA; Cha S; Banerjee A; Le TP; Lu Y; Nelson S; McKnight TR
    Int J Radiat Oncol Biol Phys; 2005 May; 62(1):20-31. PubMed ID: 15850898
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S; Ritz R; Bender B; Braun C; Pfannenberg C; Reimold M; Naegele T; Ernemann U
    Invest Radiol; 2013 May; 48(5):295-301. PubMed ID: 23296081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of cerebral glioma grade by using normal side creatine as an internal reference in multi-voxel 1H-MR spectroscopy.
    Yerli H; Ağildere AM; Ozen O; Geyik E; Atalay B; Elhan AH
    Diagn Interv Radiol; 2007 Mar; 13(1):3-9. PubMed ID: 17354186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo quantification of the metabolites in normal brain and brain tumors by proton MR spectroscopy using water as an internal standard.
    Tong Z; Yamaki T; Harada K; Houkin K
    Magn Reson Imaging; 2004 Sep; 22(7):1017-24. PubMed ID: 15288143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cho/Cr ratio at MR spectroscopy as a biomarker for cellular proliferation activity and prognosis in glioma: correlation with the expression of minichromosome maintenance protein 2.
    Gao W; Wang X; Li F; Shi W; Li H; Zeng Q
    Acta Radiol; 2019 Jan; 60(1):106-112. PubMed ID: 29665708
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human brain-structure resolved T(2) relaxation times of proton metabolites at 3 Tesla.
    Zaaraoui W; Fleysher L; Fleysher R; Liu S; Soher BJ; Gonen O
    Magn Reson Med; 2007 Jun; 57(6):983-9. PubMed ID: 17534907
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Replicability of proton MR spectroscopic imaging findings in mild traumatic brain injury: Implications for clinical applications.
    Chen AM; Gerhalter T; Dehkharghani S; Peralta R; Gajdošík M; Gajdošík M; Tordjman M; Zabludovsky J; Sheriff S; Ahn S; Babb JS; Bushnik T; Zarate A; Silver JM; Im BS; Wall SP; Madelin G; Kirov II
    Neuroimage Clin; 2023; 37():103325. PubMed ID: 36724732
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.